Development
Biodesix, Inc.
BDSX
$0.3029
$0.02117.49%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 16.53% | 18.02% | 28.59% | 8.04% | -48.46% |
| Total Depreciation and Amortization | 5.33% | -12.62% | -8.22% | -6.14% | -1.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.34% | 39.90% | -30.75% | -38.16% | 41.44% |
| Change in Net Operating Assets | -410.90% | -78.82% | 81.12% | 910.02% | 120.94% |
| Cash from Operations | -220.04% | -509.61% | 112.19% | 35.67% | -15.65% |
| Capital Expenditure | 48.92% | 8.96% | 16.40% | -297.72% | -148.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.54% | 25.45% | -83.33% | 47.37% | -50.00% |
| Cash from Investing | 48.99% | 9.10% | 16.01% | -287.82% | -143.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.33% | 0.00% | 0.00% | 99.95% | -1,070.69% |
| Issuance of Common Stock | -17.57% | 19,087.65% | -80.99% | -98.98% | 1,942.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.32% | -40.81% | 15.38% | 54.84% | -173.79% |
| Cash from Financing | 78.80% | 621.55% | 3.76% | -105.79% | 1,947.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.08% | 130.91% | 55.85% | -163.82% | 308.14% |